Therapeutics Invest Advisor

XORTX Announces Key Shareholder Meeting Information and Documentation Dispatch Aug 24, 2024

Capricor Therapeutics Issues Correction Regarding Duchenne Muscular Dystrophy Treatment Announcement Jun 26, 2024

Molecular Partners AG Unveils Promising Preclinical Results for Innovative Switch-DARPin Therapy at EHA 2024 Jun 15, 2024

Dyne Therapeutics Unveils Promising Preclinical FSHD Data from FORCE™ Platform Jun 14, 2024

LAVA Provides Business Updates and Announces Q1 2024 Financial Achievements May 21, 2024

Pliant Therapeutics Reports Promising Data from Bexotegrast Trial in Primary Sclerosing Cholangitis Feb 5, 2024

Unicycive Therapeutics Announces Upcoming Participation in Investor Conferences Nov 29, 2023

Neumora Therapeutics Embarks on Phase 1 Clinical Study for NMRA-266, Targeting Schizophrenia Treatment Nov 27, 2023

ROSEN LAW FIRM Reminds Brainstorm Cell Therapeutics Investors of Key Class Action Deadline Nov 27, 2023